1.
Progress and Clinical Evaluation of Tumor-Targeted Therapy Drugs
肿瘤靶向治疗药物的进展与临床评价
2.
Safety Research of Fe_3O_4 Nanoparticles as Carrier of Lung Magnetic Targeted Drugs Delivery System;
肺靶向治疗药物载体Fe_3O_4磁微粒的安全性研究
3.
The Synthesis of a Targeted Anti-tumor Agent-sunitinib Malate;
肿瘤靶向治疗药物苹果酸舒尼替尼的合成研究
4.
Development in chemotherapy and molecular targeted drugs of NSCLS
非小细胞肺癌化疗及分子靶向治疗药物的研究进展
5.
Experimental Study on Effects of Targeted Agents on Unfolded Protein Response in Multiple Myeloma Cells;
靶向治疗药物对骨髓瘤细胞未折叠蛋白反应影响的实验研究
6.
Utilization analysis on antineoplastic molecular targeted drugs in hospitals of 6 cities of Yangtze River valley during 2004-2007
2004—2007年长江流域6城市肿瘤靶向治疗药物利用分析
7.
Sunitinib as a molecular targeting agent in renal cell carcinoma
分子靶向药物舒尼替尼治疗肾细胞癌
8.
How to select targeted agents for advanced kidney cancer?
如何选择治疗晚期肾癌的靶向药物?
9.
Controversy on Target Therapy of Non-small Cell Lung Cancer
非小细胞肺癌靶向药物治疗争论热点
10.
Antibody-drug conjugates as targeted cancer therapeutics
靶向癌症治疗试剂——抗体-药物偶联物(英文)
11.
Pre-clinical Study on Hepatocellular Carcinoma Therapy by Targeted Gene Drug (ASOR-PLL-hIL12);
靶向基因药物（ASOR-PLL-hIL12）治疗肝癌的临床前研究
12.
A Study of Pazopanib in Chinese Patients with Metastatic Renal Cell Carcinoma;
分子靶向药物Pazopanib治疗转移性肾癌的临床研究
13.
Investigation on Medical Image Registration and Application in Heat-Triggered Drug Targeting Using Ultrasound Phased Array;
多模态图像配准研究及其在超声热导向药物靶向治疗中的应用
14.
Experimental Research of Detecting the Body Distribution of Ferrofluids by MRI in Magnetic Drug Targeting
磁性药物靶向治疗中MRI检测磁流体体内分布的实验研究
15.
One of the biggest success stories of targeted therapy is a drug called Herceptin.
靶向治疗法最成功的故事之一是一种名为贺癌平的药物。
16.
The Preliminary Study for Targeted Therapy of Glioma Based on MSCs as a Drug Vehicle;
骨髓间充质干细胞为药物载体的脑胶质瘤靶向治疗可行性研究
17.
EGFR-inhibitors Based Therapy Versus Non-EGFR-inhibitors Therapy in Metastatic Colorectal Cancer: A Meta-analysis of 10 Randomized Controlled Trials
靶向药物-EGFR抑制剂治疗转移性结直肠癌的meta分析
18.
Combination of TACE with molecularly targeted agent in management of advanced HCC
TACE联合分子靶向药物治疗原发性肝癌的研究进展